Generic Name: • Inhibits the movement of • For the • Known ➢ Constipation Assessment Nifedipine calcium ions across the management of hypersensitivity ➢ Difficulty of breathing or * History: Allergy to nifedepine, membranes of cardiac and vasospastic angina, reaction to nifedipine swallowing pregnancy, lactation. Brand name: arterial muscle cells; chronic stable ➢ Dizziness or * Physical: Skin lesions, color, edema; Adalat, Procardia, inhibition of angina and . lightheadedness orientation, reflexes; P, BP, baseline Afeditab, Nifediac transmembrane calcium hypertension ➢ Enlargement of gum tissue ECG, peripheral perfusion, flow results in the around teeth auscultation; R, adventitious sounds; Classification: depression of impulse ➢ Fast heartbeat liver evaluation, normal GI output; • Antianginal formation in a specialized ➢ Flushing (feeling of LFTs • Antihypertensive cardiac pacemaker cells, in warmth) • Calcium channel slowing the velocity of ➢ Headache Interventions: blocker conduction of the cardiac Monitor patient carefully (BP, cardiac impulse, in the depression rhythm, and output) while drug is being Dosage: of myocardial contractility, adjusted to therapeutic dose; the dosage 5g IV stat and in the dilation of may be increased more rapidly in coronary arteries and hospitalized patients under close arterioles and peripheral supervision. Do not exceed 30 mg/dose arterioles ; these effects increases. lead to decreased cardiac ➢ Ensure that patients do not chew work, decreased cardiac or divide ER tablets energy consumption, and ➢ Taper dosage of beta blockers increase delivery of oxygen before nifedepine therapy to myocardial cells. ➢ Protect drug for light and moisture.